Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Amortization - Intangibles (2023 - 2025)

Historic Amortization - Intangibles for Prime Medicine (PRME) over the last 3 years, with Q3 2025 value amounting to $752000.0.

  • Prime Medicine's Amortization - Intangibles fell 1502.82% to $752000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 5546.57%. This contributed to the annual value of $3.5 million for FY2024, which is 3822.44% down from last year.
  • Latest data reveals that Prime Medicine reported Amortization - Intangibles of $752000.0 as of Q3 2025, which was down 1502.82% from $530000.0 recorded in Q2 2025.
  • Over the past 5 years, Prime Medicine's Amortization - Intangibles peaked at $2.0 million during Q2 2023, and registered a low of $306000.0 during Q4 2024.
  • Over the past 3 years, Prime Medicine's median Amortization - Intangibles value was $857500.0 (recorded in 2024), while the average stood at $998700.0.
  • Per our database at Business Quant, Prime Medicine's Amortization - Intangibles crashed by 7282.42% in 2024 and then crashed by 1502.82% in 2025.
  • Prime Medicine's Amortization - Intangibles (Quarter) stood at $1.1 million in 2023, then crashed by 72.82% to $306000.0 in 2024, then skyrocketed by 145.75% to $752000.0 in 2025.
  • Its last three reported values are $752000.0 in Q3 2025, $530000.0 for Q2 2025, and $339000.0 during Q1 2025.